Bell Radar
New US Listings — Every Bell, Tracked
Real-time tracking of new Nasdaq and NYSE listings: what they do, how much they raised, how the first day went, and what it means for the finance leadership these companies need. Data from the Nasdaq IPO calendar, IPOScoop and StockAnalysis — every card links to the SEC prospectus for verification.
Search covers: newly listed, filed-but-not-priced, delisted and withdrawn — plus a live check across all US-listed stocks.
0Listings this month
$0KRaised this month
23SPACs tracked
+78.44%Best day-1 return
BHAIBhav Acquisition Corp II
-0.20%
US Exchange · 2026-10-29
A SPAC seeking a merger, asset acquisition, or similar business combination.
51CFO read: Requires target due diligence, valuation modeling, and post-combination financial integration planning.
Management details per the SEC prospectus.
BHAIUBHAV Acquisition Corp II
—
NASDAQ Global Market2026-10-29
A SPAC formed to effect a business combination with one or more operating companies.
51CFO read: Requires end-to-end SPAC financial governance, de-SPAC accounting, and SEC disclosure expertise.
Management details per the SEC prospectus.
SCQCSPACCircle Acquisition Corp.
-0.15%
US Exchange · 2026-10-27
2026-incorporated SPAC seeking to effect a business combination with one or more operating companies.
51CFO read: Requires CFO mastery of SPAC lifecycle financial governance, de-SPAC audit coordination, and rapid CFO transition per SEC Form 8-K/10 requir
Management details per the SEC prospectus.
GBCGeorgia Banking Company, Inc.
-36.03%
US Exchange · 2026-10-29
Regional bank in Atlanta providing deposit, lending, digital banking, and treasury solutions to individuals and businesses.
51CFO read: Requires CFO experience in community bank regulatory capital management, NIM forecasting, and IPO financial readiness amid Fed rate cycles.
Management details per the SEC prospectus.
BBTXBambusa Therapeutics
-6.31%
US Exchange · 2026-10-30
Clinical-stage biopharma developing next-generation long-acting bispecific antibodies for immunology and inflammation indications.
51CFO read: Requires CFO fluency in R&D capitalization for bispecific platforms, commercial-readiness financial modeling for I&I, and IPO disclosure gov
Management details per the SEC prospectus.
ASPEAspen Neuroscience
-0.73%
US Exchange · 2026-10-30
Clinical-stage regenerative medicine company developing autologous iPSC-derived therapies for neurodegenerative diseases like Parkinson's.
51CFO read: Requires CFO expertise in FDA clinical-stage financial compliance, CMC cost modeling for cell therapy, and IPO fundraising timing for early
Management details per the SEC prospectus.
SCQCUSPACCircle Acquisition Corp.
—
NASDAQ Global Market2026-10-27
A blank-check SPAC formed to acquire one or more operating businesses.
51CFO read: Requires CFO with SPAC merger execution, SEC compliance, and cross-border accounting integration.
Management details per the SEC prospectus.
APXCAPEX Critical Metals (Uplisting)
+41.94%
US Exchange · 2026-10-23
Engages in exploration and development of rare earth and niobium deposits; flagship is the Rift Rare Earth Project in Nebraska, USA.
51CFO read: Requires CFO with resource-sector IPO financing, SEC disclosure compliance, and project-based financial modeling.
Management details per the SEC prospectus.
DAVIDavion Healthcare (Direct Listing)
-2.92%
US Exchange · 2026-10-22
Irish PLC developing and commercializing non-invasive home diagnostic tests for early detection of health anomalies, including cancers.
51CFO read: Requires IVD regulatory pathway expertise, direct listing financial disclosure fluency, and cross-market (FDA/CE/UKCA) compliance finance ov
Management details per the SEC prospectus.
LYCALycia Therapeutics
+66.67%
US Exchange · 2026-10-23
Clinical-stage biotech developing LYTAC-based therapeutics to degrade disease-causing extracellular proteins.
51CFO read: Requires IPO financial modeling for early-stage biotech, FDA/CDER engagement experience, and platform pipeline valuation capability.
Management details per the SEC prospectus.
TCXBTCGX Acquisition Corp. II (Stock-Only)
0.00%
US Exchange · 2026-10-16
A blank-check SPAC formed to effect a merger, amalgamation, or similar business combination with one or more businesses.
51CFO read: Requires end-to-end SPAC IPO execution experience and financial oversight capability for target due diligence and post-merger integration.
Management details per the SEC prospectus.
CTYCity Therapeutics
+13.56%
US Exchange · 2026-10-16
Clinical-stage biotech developing next-gen RNAi therapeutics for thromboembolic diseases, Stargardt disease type 1, and anemia of chronic disease.
51CFO read: Requires FDA late-stage clinical filing experience, RNAi platform financial modeling, and pipeline valuation expertise.
Management details per the SEC prospectus.
FLSCFrazier Life Sciences Acquisition II (Stock-Only)
+2.90%
US Exchange · 2026-10-14
2026-incorporated blank check SPAC targeting business combinations in life sciences.
51CFO read: CFO must navigate SPAC accounting (ASC 815), M&A due diligence, and life sciences target valuation.
Management details per the SEC prospectus.
IAMIambic Therapeutics
+3.88%
US Exchange · 2026-10-15
Clinical-stage biotech integrating proprietary large-scale AI with automated chemistry/biology experimentation for drug discovery.
51CFO read: CFO must master AI-pharma monetization, R&D capitalization standards, and biotech IPO financial modeling.
Management details per the SEC prospectus.
AMROAmaero (Revived)
+3.77%
US Exchange · 2026-10-15
U.S.-based producer of high-value spherical refractory/titanium powders for AM and PM-HIP near-net-shape components.
51CFO read: CFO must bridge advanced materials manufacturing, defense/aerospace supply chain compliance, and IPO financial governance.
Management details per the SEC prospectus.
PAXGPine Tree Acquisition Corp.
-1.90%
US Exchange · 2026-10-06
A SPAC formed to effect a merger, amalgamation, asset acquisition, or similar business combination.
51CFO read: Requires end-to-end SPAC transaction execution, SEC compliance, and cross-border deal structuring capability.
Management details per the SEC prospectus.
TRXBTRex Bio, Inc.
0.00%
US Exchange · 2026-10-09
Clinical-stage biopharma developing immunoregulatory medicines, including TNFR2 agonist TRB-061, to restore immune balance in autoimmune/inflammatory diseases.
51CFO read: Requires CFO skilled in immuno-oncology/immunology pipeline valuation, clinical-data-driven investor narrative, and autoimmune-focused capit
Management details per the SEC prospectus.
RTSNRetension Pharmaceuticals
-12.25%
US Exchange · 2026-10-09
Clinical-stage biopharma developing oral PDE5 inhibitor RTN-001 for hypertension and cardiovascular diseases.
51CFO read: Requires CFO with clinical-stage biotech finance: FDA-regulated cap planning, trial cost governance, and IPO-scale fundraising execution.
Management details per the SEC prospectus.
PAXGUPine Tree Acquisition Corp.
—
NASDAQ Global Market2026-10-06
A blank-check company formed to effect a merger, capital stock exchange, or similar business combination.
51CFO read: CFO must have SPAC execution, SEC compliance, and cross-border transaction integration experience.
Management details per the SEC prospectus.
PORTSouthport Acquisition Corp. II
-0.50%
US Exchange · 2026-10-01
A SPAC formed to effect a business combination with one or more operating companies.
51CFO read: Requires CFO with SPAC lifecycle governance, SEC compliance, and M&A integration expertise.
Management details per the SEC prospectus.
PORTUSouthport Acquisition Corp. II
—
NYSE2026-10-01
Second blank-check SPAC seeking to acquire a yet-to-be-identified private company.
51CFO read: CFO must master SPAC merger accounting, De-SPAC financial integration, and SEC Form 8-K/10 registration filing.
Management details per the SEC prospectus.
CHWMChilwa Minerals Ltd
—
NASDAQ Capital Market2026-10-01
Mineral exploration company focused on heavy mineral sands and rare earth elements at Lake Chilwa, Malawi.
51CFO read: CFO must have resource-sector IPO financial modeling, ESG disclosure compliance, and emerging-market project accounting experience.
Management details per the SEC prospectus.
RZAIROZE AI INC.
—
NASDAQ Capital Market2026-09-29
Disaster prevention AI company offering a wireless-sensor-based fire detection and alert platform.
51CFO read: Requires CFO with compliance-driven financial controls and experience in government/military revenue recognition.
Management details per the SEC prospectus.
ACCVAccelevation Holdings Corp.
-1.56%
US Exchange · 2026-09-30
Vertically integrated provider of power distribution and white space infrastructure for AI, cloud, and hyperscale data centers
51CFO read: Requires combined expertise in heavy-asset manufacturing ops, large-scale infrastructure project delivery, and technical marketing to data c
Management details per the SEC prospectus.
THEOBOA Acquisition Corp. II
-0.95%
US Exchange · 2026-08-04
A SPAC targeting business combinations in digital & energy infrastructure, real estate, and real assets.
51CFO read: Requires financial modeling expertise in infrastructure/real estate plus SPAC-specific governance experience.
Management details per the SEC prospectus.
FJDIARC Group Securities Acquisition I
-1.35%
US Exchange · 2026-08-04
A SPAC formed to effect a merger, amalgamation, share exchange, asset acquisition, or similar business combination.
51CFO read: Must master post-IPO target search pacing, PIPE financing execution, and multi-state regulatory coordination.
Management details per the SEC prospectus.
PNAQPinnacle Acquisition Corporation
-1.80%
US Exchange · 2026-08-07
A SPAC formed to effect a merger, amalgamation, share exchange, asset acquisition, or similar business combination.
51CFO read: Requires end-to-end SPAC execution capability: SEC compliance, due diligence coordination, and target valuation negotiation.
Management details per the SEC prospectus.
TBCVThunder Bridge Capital Partners V, Ltd.
-2.19%
US Exchange · 2026-08-13
Blank check company formed to effect a business combination via merger, reorganization, asset acquisition, etc. (SPAC).
51CFO read: Requires SPAC sponsor coordination, cross-border transaction financial structuring capability.
Management details per the SEC prospectus.
NSAINorthstrive Acquisition Corp I.
-1.20%
US Exchange · 2026-08-18
Blank check company formed to complete a business combination through merger, share exchange, asset acquisition, etc. (SPAC).
51CFO read: Requires post-IPO due diligence management, valuation modeling, and regulatory engagement skills.
Management details per the SEC prospectus.
SCATSouthern Cross Acquisition II Corp
-0.80%
US Exchange · 2026-08-26
Blank check company formed to effect a business combination via merger, asset acquisition, reorganization, etc. (SPAC).
51CFO read: Requires SPAC structuring, target screening, and transaction execution financial oversight.
Management details per the SEC prospectus.
BRRKUBluerock Acquisition Corp. II
—
NASDAQ Global Market2026-09-25
Blank check company formed to acquire a target business (SPAC).
51CFO read: Requires full SPAC lifecycle expertise, SEC compliance, and M&A financial integration capability.
Management details per the SEC prospectus.
RNAQRainier Acquisition Corporation
-0.20%
US Exchange · 2026-08-27
Formerly healthcare-focused SPAC; now a general-purpose SPAC pursuing business combinations across sectors.
51CFO read: Requires financial strategy pivoting and disclosure restructuring from healthcare-focused to cross-sector SPAC.
Management details per the SEC prospectus.
IPHXInflection Point Acquisition Corp. VIII
-1.40%
US Exchange · 2026-08-28
A blank-check SPAC seeking a business combination with one or more operating companies.
51CFO read: Requires mastery of SPAC lifecycle financial governance and NASDAQ/NYSE listing compliance execution.
Management details per the SEC prospectus.
TLACThree Lions Acquisition Corp.
-1.50%
US Exchange · 2026-09-01
A SPAC targeting business combinations in sports, hospitality, leisure, and related consumer sectors.
51CFO read: Requires M&A valuation and integrated financial modeling across sports, hospitality, and consumer verticals.
Management details per the SEC prospectus.
HYACHaymaker Acquisition Corp V
-0.05%
US Exchange · 2026-09-17
A blank-check SPAC seeking a business combination with one or more operating companies.
51CFO read: Requires end-to-end SPAC accounting, de-SPAC financial reporting, and SEC filing expertise.
Management details per the SEC prospectus.
LEDRLeader's Advantage Acquisition Corp.
-0.33%
US Exchange · 2026-09-18
A special purpose acquisition company (SPAC) seeking a business combination with one or more entities.
51CFO read: Requires familiarity with SPAC sponsor collaboration, financial due diligence support, and combination accounting.
Management details per the SEC prospectus.
LOVILive Oak Acquisition Corp. VI
—
US Exchange · 2026-09-23
A blank-check company (SPAC) formed to effect a business combination with an operating company.
51CFO read: Requires CFO capability in SPAC lifecycle management, trust account oversight, and De-SPAC financial structuring.
Management details per the SEC prospectus.
BRRKBluerock Acquisition Corp. II
-0.40%
US Exchange · 2026-09-25
A SPAC focused on effecting a business combination with one or more operating companies.
51CFO read: Requires CFO expertise in post-IPO SPAC merger execution, PIPE financing, and SEC-compliant financial integration.
Management details per the SEC prospectus.
APMDApnimed
+78.44%
US Exchange · 2026-07-31
Develops novel oral therapies targeting neuromuscular dysfunction in obstructive sleep apnea.
51CFO read: Requires CFO expertise in clinical-stage biopharma financial governance and FDA-path capital planning.
Management details per the SEC prospectus.
TCGXTCGX Acquisition (Stock-Only)
+25.10%
US Exchange · 2026-08-05
2026-incorporated blank check company seeking a business combination via merger, asset acquisition, or similar transaction.
51CFO read: CFO must navigate SPAC accounting rules, target due diligence financial frameworks, and post-merger financial integration governance.
Management details per the SEC prospectus.
ATTOAttovia Therapeutics
+0.82%
US Exchange · 2026-08-05
Clinical-stage biopharma developing biparatopic biologics (ATTOBODY platform) for immune-mediated pruritic diseases.
51CFO read: CFO requires CMC cost modeling, rare-disease commercial readiness planning, and platform-technology valuation expertise.
Management details per the SEC prospectus.
BRVEBraveheart Bio
+12.22%
US Exchange · 2026-08-06
Clinical-stage biopharma developing oral small-molecule cardiac myosin inhibitors for hypertrophic cardiomyopathy (HCM).
51CFO read: CFO must master clinical-stage financial modeling, FDA development pathway capital planning, and biopharma capital efficiency.
Management details per the SEC prospectus.
TPTicketplus
-4.38%
US Exchange · 2026-08-07
Full-stack event platform for live entertainment across Latin America: discovery, primary ticketing, access control, payments, analytics & insights.
51CFO read: CFO must balance SaaS P&L ownership, cross-border payment compliance, and LATAM market expansion execution.
Management details per the SEC prospectus.
LTGOLatigo Biotherapeutics
-7.22%
US Exchange · 2026-08-07
Clinical-stage biotech developing non-opioid NaV1.8 inhibitors for acute and chronic pain indications.
51CFO read: CFO must navigate pain therapy market access, alternative payment models, and pre-commercial finance planning.
Management details per the SEC prospectus.
BLSMBlossomHill Therapeutics
-1.25%
US Exchange · 2026-08-07
Clinical-stage biopharma developing small molecule medicines for oncology, including EGFR-mutant NSCLC and R/R AML.
51CFO read: CFO must handle oncology pipeline valuation, partnership deal structuring, and global clinical trial finance.
Management details per the SEC prospectus.
VOGXVogenx
+75.31%
US Exchange · 2026-08-12
Clinical-stage biopharma developing therapeutics for metabolic disorders including post-bariatric hypoglycemia and gastroparesis.
51CFO read: CFO must master clinical-stage financial modeling, payer strategy, and FDA regulatory timing.
Management details per the SEC prospectus.
SNSCSunScout Holding Ltd.
-68.80%
US Exchange · 2026-08-12
Designs, manufactures, and commercializes autonomous, solar-powered robotic mowers and solar energy solutions.
51CFO read: CFO must bridge hardware manufacturing, solar energy integration, and consumer product commercialization.
Management details per the SEC prospectus.
FOILLondian Wason New Energy Tech
-26.09%
US Exchange · 2026-08-12
Global manufacturer of electrolytic copper foil for lithium batteries and PCBs.
51CFO read: CFO must handle manufacturing cost accounting, cross-border tax optimization, and commodity price risk.
Management details per the SEC prospectus.
RVIIRobinhood Ventures Fund II (Closed End)
-6.36%
US Exchange · 2026-08-13
Closed-end BDC investing primarily in early-stage private growth companies.
51CFO read: CFO requires BDC accounting expertise, fair-value modeling, and SEC periodic reporting rigor.
Management details per the SEC prospectus.
LYNXLyntris
-11.14%
US Exchange · 2026-08-19
Defense tech firm delivering sensor and connectivity solutions across land, sea, air, and space domains.
51CFO read: CFO must master DoD contract accounting, revenue recognition, and capitalized R&D controls.
Management details per the SEC prospectus.
QNBCQNB Corp. (Uplisting)
+8.59%
US Exchange · 2026-08-20
U.S. commercial and retail bank offering deposit, lending, and brokerage services.
51CFO read: CFO must balance banking regulatory compliance with wealth management business scaling.
Management details per the SEC prospectus.
FBDTFirst Breach (Direct Listing)
-91.33%
US Exchange · 2026-08-20
US-based manufacturer of ammunition components and civilian/defense drones, sold via e-commerce and distributors.
51CFO read: CFO requires defense supply chain finance control, export compliance accounting, and high-risk industry internal controls.
Management details per the SEC prospectus.
ADBTAdvasa Holdings (Direct Listing)
-99.00%
US Exchange · 2026-08-25
Japan-based fintech offering FUKUPE, a patented Earned Wage Access platform for real-time payroll access.
51CFO read: CFO must navigate cross-border fintech regulation, SaaS revenue recognition, and Japan-specific compliance.
Management details per the SEC prospectus.
JTTTJATT III Acquisition (Stock-Only)
+10.02%
US Exchange · 2026-08-26
Newly formed blank check company seeking a business combination via merger, acquisition, or reorganization.
51CFO read: CFO must master SPAC accounting, SEC business combination disclosures, and deal structure design.
Management details per the SEC prospectus.
ASBHAmerican Savings Bank of Hawaii
+11.81%
US Exchange · 2026-09-16
Hawaii-based national bank offering deposits, lending, payment, investment advisory, and insurance services.
51CFO read: CFO must combine regional banking compliance expertise with IPO financial reporting rigor.
Management details per the SEC prospectus.
ADRXADARx Pharmaceuticals
+17.29%
US Exchange · 2026-09-25
A clinical-stage biotech developing hepatic-targeted siRNA therapeutics for diverse diseases, including HAE and stroke prevention.
51CFO read: Requires deep biotech capital cycle fluency, clinical pipeline valuation modeling, dual FDA/SEC disclosure timing management, and R&D expens
Management details per the SEC prospectus.
TLACUThree Lions Acquisition Corp.
—
NASDAQ Global Market2026-09-01
A blank-check company formed to acquire one or more businesses through merger, share exchange, asset acquisition, or similar transaction.
51CFO read: Requires expertise in SPAC formation, target screening, PIPE financing coordination, and rapid transition into post-merger CFO role.
Management details per the SEC prospectus.
TRBGTurbogen Ltd.
0.00%
NASDAQ Capital Market2026-09-03
Develops and produces micro-turbine combined cooling, heating, and power (CCHP) systems for buildings, with multi-fuel capability.
51CFO read: Requires hardware energy commercialization experience, cross-border financial modeling (Israel), and IPO-stage international compliance over
Management details per the SEC prospectus.
HYACUHaymaker Acquisition Corp V
—
NYSE2026-09-17
A blank-check company formed to effect a merger, capital stock exchange, asset acquisition, or similar business combination.
51CFO read: Requires full SPAC lifecycle expertise, especially in M&A due diligence, deal structuring, and SEC filing compliance.
Management details per the SEC prospectus.
LEDRULeader's Advantage Acquisition Corp.
—
NASDAQ Global Market2026-09-18
A blank-check company formed for the purpose of acquiring an undisclosed business.
51CFO read: Requires SPAC liquidation/merger financial oversight and SEC filing compliance expertise.
Management details per the SEC prospectus.
Reading the sample
Four things this sample tells you
Every figure below is computed from the table above at render time, not fixed copy. Structure matters more than the list: the same batch of listings can only take certain routes.
One: 23 of 60 are SPACs, 37 are operating companies
SPACs are 38% of the sample. They have to be read separately: a SPAC's raise went into trust at listing and is not operating-company capital. Averaging the two together produces a number that means nothing.
Two: median raise $130M, and 6 below US$25 million
Among operating companies: 16 raised US$100 million or more, 7 raised US$25-100 million, 6 raised below US$25 million. That distribution matters directly for a China-based issuer: Nasdaq Rule 5210(l), effective 2026, requires a firm-commitment IPO of at least US$25 million. Below that line the IPO route is closed to a China-based issuer — a reverse merger or a SPAC is the remaining path, and the post-combination MVUPHS must still be at least US$25 million.
Three: 49 have a quoted return, 15 closed up (31%), median -0.5%
The first day mostly reflects how much room the pricing left and how small the float is, not long-term quality. Treating a first-day pop as the definition of a successful listing is the most common misreading in this market — and a break below the offer price is not a failed project either.
Why it matters
What this table is actually for, if you plan to list
As a peer sample: how companies your size actually did it
You can find companies in your sector and at your raise size: which tier they chose, where they priced, how the first day went. That is more specific than an industry report, because every card links to the SEC prospectus for verification.
Working backwards: the 12-18 months before the bell are the point
A company ringing the bell today spent the previous 12-18 months on audit remediation, US GAAP conversion, controls and SEC comment responses. The useful question is not how much it raised, but which step you should start today if you want to list in 12-18 months.
Data boundaries
All figures come from public records on the Nasdaq IPO calendar, IPOScoop and StockAnalysis, refreshed daily. We add no subjective overlay and make no share-price forecasts. This is not investment advice, and it does not imply that any company listed here is a client or partner of 51CFO.
NASDAQ and NYSE — what are the tiers inside?
NASDAQ: three listing tiers
Global Select MarketHighest bar: financial, cap and governance standards on par with the NYSE main board. Large, mature issuers.
Global MarketThe middle tier: mostly mid-cap growth companies.
Capital MarketLowest bar: small-caps and early-stage issuers. Most China-based IPOs and SPACs land here — the tier we watch closest.
NYSE: three markets
NYSE (main board)Blue chips: the oldest and strictest board, the default for large issuers.
NYSE AmericanFormerly AMEX: small and mid-cap companies.
NYSE ArcaPrimarily ETFs and other fund products; operating-company IPOs are rare.
Note: OTC markets (OTCQX / OTCQB / Pink) are off-exchange trading, not exchange listings — Bell Radar does not track them. Each tier carries different disclosure and governance demands, which is exactly what shapes the CFO profile you need.
Delisted
Recently delisted from Nasdaq / NYSE
0 delistings this month; 363 tracked in total. A delisting usually means an emergency CFO-level cleanup — audits, wind-downs, or take-private deals.
| Delisted on | Symbol | Company | Status |
|---|---|---|---|
| 2026-10-30 | GCTK | Glucotrack Inc | Delisted |
| 2026-10-29 | LNAI | Lunai Bioworks Inc | Delisted |
| 2026-10-29 | DYNC | Dynamix Corp | Delisted |
| 2026-10-26 | ELMES | Elme Communities | Delisted |
| 2026-10-23 | WEAV | Weave Communications Inc | Delisted |
| 2026-10-23 | SDST | Stardust Power Inc | Delisted |
| 2026-10-22 | PERF | Perfect Corp | Delisted |
| 2026-10-22 | NATH | Nathans Famous Inc | Delisted |
| 2026-10-22 | ACA | Arcosa Inc | Delisted |
| 2026-10-19 | BZH | Beazer Homes Usa Inc | Delisted |
| 2026-10-16 | ATKR | Atkore Inc | Delisted |
| 2026-10-16 | ACVA | Acv Auctions Inc | Delisted |
| 2026-10-14 | CCO | Clear Channel Outdoor Holdings Inc | Delisted |
| 2026-10-09 | NVNIF | Nvni Group Ltd. | Delisted |
| 2026-10-09 | MAMK | Maxsmaking Inc | Delisted |
| 2026-10-09 | ILLR | Triller Group Inc | Delisted |
| 2026-10-06 | TWOD | Two Harbors Investment Corp | Delisted |
| 2026-10-06 | LESLQ | Leslie's Inc | Delisted |
| 2026-10-06 | GWHT | Ess Tech Inc | Delisted |
| 2026-10-05 | WBD | Warner Bros Discovery Inc | Delisted |
| 2026-10-05 | WALDF | Waldencast PLC | Delisted |
| 2026-10-05 | SLP | Simulations Plus Inc | Delisted |
| 2026-10-05 | DRCT | Direct Digital Holdings Inc | Delisted |
| 2026-10-05 | BLFS | Biolife Solutions Inc | Delisted |
| 2026-10-02 | QRVO | Qorvo Inc | Delisted |
| 2026-10-02 | GETY | Getty Images Holdings Inc | Delisted |
| 2026-09-30 | NSTS | Nsts Bancorp Inc | Delisted |
| 2026-09-30 | FSEA | First Seacoast Bancorp Inc | Delisted |
| 2026-09-30 | AMZE | Amaze Holdings Inc | Delisted |
| 2026-09-29 | GBTG | Global Business Travel Group Inc | Delisted |
Get the bell-ringing brief every week
Every new Nasdaq / NYSE listing — what they do, how much they raised, first-day performance, and the finance-leadership angle. One email a week.
FAQ
Common questions
Where does the Bell Radar data come from?
Public data from the Nasdaq IPO calendar, IPOScoop and StockAnalysis, refreshed daily. Every card links through to that company's SEC filing so you can verify it yourself; we add no subjective overlay.
How often is it updated?
Daily. Three lists are maintained separately — newly listed, filed (S-1/F-1 submitted) and delisted — and new listings land on the trading day they price.
Why track the finance leadership needs of these companies?
A bell means the company spent the previous 12–18 months on audit remediation, US GAAP conversion, controls and SEC filings. Those hiring needs happen before the listing, not after. That stretch is exactly what 51CFO works on: placing Western CFOs who have completed a full US IPO cycle, and building out the rest of the listing team, for Chinese and Chinese-founded companies.
What is the delisted list?
Companies that have left Nasdaq or NYSE. For a company planning to list it is the other half of the sample: listing is not the finish line, and staying listed takes continuous SEC reporting and controls capability.
Are any of these companies 51CFO clients?
No. The Bell Radar is an observation built on public data. It is not investment advice and does not imply that any company on it is a client or partner of 51CFO.